News
Howmet Q2 Earnings Preview: Should You Buy the Stock Now or Wait?
Howmet Aerospace Inc. HWM is scheduled to release second-quarter 2025 results on July 31, before market open. The Zacks Consensus Estimate for earnings is currently pegged at 87 cents per share on
Veralto Q2 Earnings & Revenues Beat Estimates, Increase Y/Y
Veralto Corporation VLTO reported impressive second-quarter 2025 results, with earnings and revenues beating the Zacks Consensus Estimate.
Quarterly adjusted earnings of 93 cents per share surpassed
Masco to Report Q2 Earnings: Here's What Investors Must Know
Masco Corporation MAS is scheduled to report its second-quarter 2025 results on July 31, before the opening bell.In the last reported quarter, the company’s adjusted earnings and net sales missed
4 Manufacturing Electronics Stocks to Consider on Robust Industry Trends
QBTS Rides AI & Blockchain Wave: Will the Rally Last After Q2 Release?
D-Wave Quantum’s QBTS increasing emphasis on artificial intelligence and blockchain represents a strategic expansion of its quantum system sales pipeline. The company in the first quarter of 2025
Camtek (CAMT) Earnings Expected to Grow: Should You Buy?
The market expects Camtek (CAMT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is
Carlyle Secured Lending, Inc. (CGBD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Carlyle Secured Lending, Inc. (CGBD) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known
Analysts Estimate Celsius Holdings Inc. (CELH) to Report a Decline in Earnings: What to Look Out for
Celsius Holdings Inc. (CELH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus
Clearway Energy (CWEN) Reports Next Week: Wall Street Expects Earnings Growth
Clearway Energy (CWEN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook
Ball (BALL) Earnings Expected to Grow: Should You Buy?
The market expects Ball (BALL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is
Will Beam Therapeutics Inc. (BEAM) Report Negative Q2 Earnings? What You Should Know
The market expects Beam Therapeutics Inc. (BEAM) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known
BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when BridgeBio Pharma (BBIO) reports results for the quarter ended June 2025. While this widely-known consensus outlook
The Baldwin Insurance Group (BWIN) Reports Next Week: Wall Street Expects Earnings Growth
The Baldwin Insurance Group (BWIN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known
Angel Oak Mortgage (AOMR) Earnings Expected to Grow: Should You Buy?
Angel Oak Mortgage (AOMR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus
Arista Networks (ANET) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Arista Networks (ANET) reports results for the quarter ended June 2025. While this widely-known consensus outlook
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Wall Street expects a year-over-year increase in earnings on higher revenues when ANI Pharmaceuticals (ANIP) reports results for the quarter ended June 2025. While this widely-known consensus
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
AxoGen (AXGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a
Analysts Estimate Ardent Health, Inc. (ARDT) to Report a Decline in Earnings: What to Look Out for
Ardent Health, Inc. (ARDT) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus
AdaptHealth Corp. (AHCO) Expected to Beat Earnings Estimates: Should You Buy?
AdaptHealth Corp. (AHCO) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
Amneal Pharmaceuticals (AMRX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
Amgen (AMGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a
Alight, Inc. (ALIT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Wall Street expects a year-over-year decline in earnings on lower revenues when Alight, Inc. (ALIT) reports results for the quarter ended June 2025. While this widely-known consensus outlook is
AC Immune (ACIU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
The market expects AC Immune (ACIU) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook